Abstract:Intermittent arrest with esmolol did not enhance protection of intermittent crossclamping with fibrillation; however, multiple esmolol infusions during global ischemia provided improved protection. Administration (constant flow or constant pressure) of arresting solutions influenced outcome only during continuous infusion. Multidose esmolol arrest may be a beneficial alternative to intermittent crossclamping with fibrillation or conventional cardioplegia.
“…The results of the present study also confi rm the reported features of esmolol; i.e., esmolol inhibits MVO 2 dose-dependently and has myocardial protective effects. Furthermore, myocardial contraction in the presence of esmolol at 1 · 10 −4 M was almost zero in the present study, whereas at higher concentrations (approximately 1.0 mM), esmolol was reported to induce cardiac arrest [21].…”
Our results indicate that in the isolated rabbit heart, landiolol and esmolol had equipotent negative chronotropic effects, however, landiolol had a less potent negative inotropic effect than esmolol.
“…The results of the present study also confi rm the reported features of esmolol; i.e., esmolol inhibits MVO 2 dose-dependently and has myocardial protective effects. Furthermore, myocardial contraction in the presence of esmolol at 1 · 10 −4 M was almost zero in the present study, whereas at higher concentrations (approximately 1.0 mM), esmolol was reported to induce cardiac arrest [21].…”
Our results indicate that in the isolated rabbit heart, landiolol and esmolol had equipotent negative chronotropic effects, however, landiolol had a less potent negative inotropic effect than esmolol.
“…36 Moreover, some studies using esmolol, another ultrashort-acting β-blocker, reported that β-blockers have a cardioprotective effect during reperfusion through various mechanisms. 37,38 Although landiolol is classifi ed an ultrashort-acting β-blocker, it exerts approximately nine times more potent β-blocking activity in vivo than esmolol and is eight times more cardioselective in vitro. 39 Moreover, the suppressive effects on cardiovascular performance are signifi cantly less potent for landiolol than those of esmolol at equipotent β-blocking doses.…”
Intraoperative and perioperative administration of low-dose landiolol has a preventive effect on the appearance of atrial fibrillation after CABG surgery.
“…However, it was pointed out that the hypotension could be avoided by careful titration, since esmolol has such a short duration of action. Esmolol has even been used for cardioplegia with an optimal arresting dose of 1.0 mmol/L (19). This is understandable if it is appreciated that esmolol, apart from being a clinically valuable beta blocking agent, also exhibits a blocking effect on the calcium current.…”
Apart from being a beta adrenergic blocker esmolol also exerts a direct negative inotropic effect on cardiac muscle due to its inhibition of the calcium current during the action potential.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.